HC Deb 18 April 1991 vol 189 cc246-7W
Mr. Worthington

To ask the Secretary of State for Scotland how vacation hardship allowance is calculated.

Mr. Michael Forsyth

The vacation hardship allowance may be used to provide student maintenance outwith term time in certain defined circumstances. Its maximum value is broadly similar to the additional weeks allowance for students on courses with extended terms and in recent years this has been increased to reflect the movement in student maintenance rates generally. The amount actually payable in any individual case depends on the circumstances of the applicant.

On 27 March, my hon. Friend the Under-Secretary of State for Education and Science announced that, subject to the approval of the necessary regulations, the equivalent discretionary allowance would be discontinued in England and Wales. Those regulations come into force on 17 April and I can confirm that it is our intention to discontinue this allowance in Scotland also.

Health board Application received Current status
Argyll and Clyde 1 Commenced fundholding 1 April 1991
Greater Glasgow 1 Application received March 1991: currently under consideration
Lothian 1 Commenced fundholding 1 April 1991
Tayside 2 Recognition granted; date of commencement still to be set.

Practices in Scotland may submit applications at any time during the course of a year. It is for the health board to determine and agree in consultation with the individual practices concerned the date on which recognition takes effect, and the date of commencement.

Number of vials/bottles produced by the Scottish National Blood Transfusion Service Years ending 31 March—to NHS, private sector. No products were issued to other bodies in the period
Product 1986–87 1987–88 1988–89 1989–90
Vials or bottles NHS Private sector NHS Private sector NHS Private sector NHS Private sector
Factor 8 Vials 37,243 52,204 41,335 42,798
Factor IX (DEFIX) Vials 1,013 9,614 9,160 7,812
Intramuscular IgG
Normal IgG Vials 6,735 30 8,592 7 14,200 7 15,225
Anti-D IgG Vials 12,870 54 16,693 44 16,935 22 16,637 36
Anti-tetanus IgG Vials 4,934 4,555 4,175 3,904
Hepatitis (HBs) IgG Vials 601 734 1 1,519 1,320
Varicella Zoster Vials 393 400 490 550
Rubella IgG Vials 170 120 20 315
Rabies IgG Vials 40 195 53 30
Measles IgG Vials 175 70 65 203
Intravenous IgG
Normal IgG Vials 4,970 7,919 8,485 10,854
CMV IgG Vials 64 817 1,291 902
Measles IgG Vials 20 65 46
Tetanus IgG Vials 5 88 8 62
Albumin Bottles 2,490 6,642 6,426 4,692
SPPS Bottles 75,258 4 93,594 16 88,631 84,378

Note: Products are made available to the private sector only when all NHS needs are fully covered.

Mr. Galbraith

To ask the Secretary of State for Scotland if he will give, for the past 10 years, the number of units of blood used in(a) NHS hospitals and (b) private hospitals.